SAM #HT9426-26-NOI-TNM

Sole Source Intent: Cardiac Output Monitoring System for USAISR

This notice announces the Defense Health Agency Contracting Activity's intent to award a sole source contract for a cardiac output monitoring system to Becton, Dickinson and Company (BD) for the U.S. Army Institute of Surgical Research (USAISR). - Agency: Defense Health Agency Contracting Activity (DHACA) for USAISR, Joint Base San Antonio, TX - Sole source vendor: Becton, Dickinson and Company (BD) - Requirement: Advanced cardiac output monitoring system - Must integrate invasive and non-invasive sensors with predictive software - Required compatibility with DREW data acquisition system (used for swine research) - Must support Swan-Ganz catheter monitoring (Edwards Lifesciences 7.5 FR Swan-Ganz CCOmbo V set or equivalent) - System must measure multiple hemodynamic parameters (e.g., cardiac output, stroke volume, systemic vascular resistance, etc.) - Must meet specific environmental, connectivity, and physical requirements - No specific part numbers or quantities provided - Interested parties may submit capability statements demonstrating their ability to meet all requirements - OEMs referenced: Becton, Dickinson and Company (BD) and Edwards Lifesciences (for the Swan-Ganz catheter) - Commercial opportunity for vendors with compatible cardiac output monitoring solutions

Description

NOTICE OF INTENT TO SOLE SOURCE:

This is a Notice of Intent to award a Sole Source contract on the basis of other than full and open competition in accordance with the Federal Acquisition Regulation (FAR) 6.302-1, as the unique services are only available from one source and awarding to any other source would not fulfill the agency’s requirements. This is not a Request for Quotes or Proposals. No contract award will be made on the basis of the responses to this notice. The purpose of this notice is to allow interested parties to assert and explain their capability to perform the work described.

The Defense Health Agency Contracting Activity (DHACA) located at 808 Schreider Street, Fort Detrick, MD on behalf of the U.S. Army Institute of Surgical Research (USAISR), Joint Base San Antonio, TX intends to award a sole source firm fixed price contract to Becton, Dickinson and Company (a.k.a. BD) to acquire an advance cardiac output monitoring system.

PROGRAM DESCRIPTION

   The required supply item is an advanced hemodynamic monitoring platform that integrates invasive and non-invasive sensors with predictive software to optimize patient management. The USAISR requires a high-quality cardiac monitoring system to support large animal research studies.

The system needs to be able to combine predictive analytics, multi-parameter integration, and broad compatibility into a single platform, enabling clinicians to anticipate and prevent critical events.

The equipment must be able to connect and communicate with the currently used DREW data acquisition system utilized for swine research protocols. The inability to meet these requirements will inhibit our ability to compare historical data thus resulting in potential loss of data, and efforts.

REQUIRED CAPABILITIES

Minimum Essential Characteristics (MECs): Cardiac Monitoring Platform

The USAISR seeks a device that can monitor cardiac output (CO) and derive hemodynamic parameters in a hospital setting. We are seeking a CO monitoring device that utilizes a Swan Ganz catheter to monitor hemodynamic parameters. The device’s proprietary coded output must be compatible with USAISR’s unique internal data logging systems. This is required to maintain historic and current protocol data continuity and workflow. Inability to meet these requirements will inhibit comparisons of current and future studies to USAISR historical data resulting in loss of data, and efforts.

The CO Monitoring Platform shall have the following specifications:

Ability to measure the following: mixed venous oxygen saturation (SvO2), cardiac output (CO), stroke volume (SV), systemic vascular resistance (SVR), right ventricular ejection fraction (RVEF), right ventricular end diastolic volume (RVEDV), pulmonary artery pressure (PAP), and pulmonary artery occlusion pressure (PAOP). Utilization of the Edwards Lifesciences 7.5 FR Swan-Ganz CCOmbo V set or a Swan-Ganz of equal functionality and performance that provides continuous monitoring of SvO2 and measures continuous calculation of cardiac output by using thermodilution principles. Equipment dimensions equal to or smaller than 342 x 388 x 208 mm (height x width x depth) Equipment shall weigh less than 22 lbs Equipment ingress protection of at least IPX1 Display size of at least 15 inches. At least two (2) COM1 serial port connectors, RS-232 Operational environmental specifications: Temperature range: 0 to 37℃ Relative humidity: 10-90% non-condensing Altitude: 0 to 3,000 meters Transportation environmental specifications: Temperature range: -18 to 45℃ Relative humidity: 20 to 90% non-condensing Altitude: Maximum 6,096 m for up to 8 hours Monitor battery must have these technical characteristics: Output voltage (nominal) 14.4 V Maximum discharge current 4.096 A (8.5 A at 25℃) Cells 8 x Li-Ion (lithium ion) Monitoring platform technical specifications: Input/Output Projective capacitive touch screen At least two (2) RS-232 serial ports: Maximum data rate = 57.6 kilo baud At least three (3) USB ports: 2 x USB 3.0; 1 x USB 2.0 At least one (1) RJ-45 ethernet port At least one (1) HDMI port  Heart Rate average display Response time: 40 seconds for step increase from 80 to 120 BPM, 29 seconds for step decrease from 80 to 40 BPM. CO monitoring on: Averaging time: Time between CO measurements (3 to 21 minutes); Update rate: Approximately 1 minute; Response time: 175 seconds for step increase from 80 to 120 BPM, 176 seconds for step decrease from 80 to 40 BPM. Electrical Rated supply voltage: 100 to 240 Vac; 50/60 Hz Rated input: 1.5 to 2.0 Amps Fuses: T 2.5AH, 250V; High breaking capacity; Ceramic Alarm Sound pressure level: 45 to 85 dB(A) Utilization of a Swan-Ganz™ patient cable with the following parameter measurement specifications: Continuous Cardiac Output Range: 1 – 20 Liter/minute Reproducibility: ±6% or 0.1 Liter/minute, whichever is greater Maximum thermal filament surface temperature 48℃ Intermittent (bolus) Cardiac Output Range: 1 – 20 Liter/minute Reproducibility: ±3% or 0.1 Liter/minute, whichever is greater Blood temperature Range: 15 to 45℃ Accuracy: ±3℃ Roll Stand: Compatible rolling stand with bracket and plates for cardiac output monitoring system Base Dimensions: 12-15 inches wide x 10-12 inches deep to allow Height: Non-specific but need to be adjustable Warranty and Product Support: 12-month standard warranty 24-month product support and protection plan

ELIGIBILITY

The applicable NAICS code for this requirement is 339113 (Surgical Appliance and Supplies Manufacturing).

The Product Service Code is 6515 - Medical and Surgical Instruments. Equipment and Supplies; CM Level 2 Spend Category: 10.2 Medical Equipment and Accessories and Supplies.

SUBMISSION DETAILS

Responses should appear on company letterhead and include affirmation of active registration in the System of Award Management (SAM), your qualifications and any other applicable data or information. Additionally, respondents should indicate whether they are a large business, small business, small-disadvantaged business, 8(a) concern, woman-owned small business, HUBZone, service-disabled veteran-owned small business, or qualify as socially or economically disadvantaged and whether they are U.S. or foreign owned.

If your organization has the potential capacity to provide the required services, please provide the following information: 1) Organization name, address, primary points of contact (POCs) and their email address, FAX, Web site address, telephone number, and type of ownership for the organization, DUNS number; and 2) a tailored capability statement addressing the requirements of this notice, with appropriate documentation supporting claims of organizational and staff capability. If significant subcontracting or teaming is anticipated in order to deliver technical capabilities, organizations should address the administrative and management structure of such arrangements.

Interested businesses should submit a brief capabilities statement package (no more than ten pages, with font no smaller than 10 point) demonstrating ability to provide the services listed in the required capabilities description. Documentation should be in bullet format.

Your response to this Notice of Intent, including any capabilities statement, shall be electronically submitted to the Contract Specialist, Tammy McRae, in either Microsoft Word or Portable Document Format (PDF), via email to tammy.n.mcrae.civ@health.mil no later than 5:00 p.m. Eastern Standard Time on 18 August 2026 and reference the Notice ID number shown above in the subject line of your e-mail and on all enclosed documents. Information and materials submitted in response to this request WILL NOT be returned. DO NOT SUBMIT CLASSIFIED MATERIAL.

All data received in response to this Notice of Intent that is marked or designated as corporate or proprietary will be fully protected from any release outside of the Government. Responses to this notice will be used to determine the availability of this type of service. All responsible sources may respond to this notice, and all responses will be considered by the agency.

View original listing